ES2532985T3 - Proteínas quiméricas de toxoide de Shiga - Google Patents
Proteínas quiméricas de toxoide de Shiga Download PDFInfo
- Publication number
- ES2532985T3 ES2532985T3 ES07751283.8T ES07751283T ES2532985T3 ES 2532985 T3 ES2532985 T3 ES 2532985T3 ES 07751283 T ES07751283 T ES 07751283T ES 2532985 T3 ES2532985 T3 ES 2532985T3
- Authority
- ES
- Spain
- Prior art keywords
- polypeptide
- stxa2
- chimeric proteins
- subunit
- shiga toxoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 2
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- 108010091769 Shiga Toxin 1 Proteins 0.000 abstract 1
- 108010090763 Shiga Toxin 2 Proteins 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77365806P | 2006-02-16 | 2006-02-16 | |
| US773658P | 2006-02-16 | ||
| PCT/US2007/004513 WO2007098201A2 (en) | 2006-02-16 | 2007-02-16 | Shiga toxoid chimeric proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2532985T3 true ES2532985T3 (es) | 2015-04-06 |
Family
ID=38437976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07751283.8T Active ES2532985T3 (es) | 2006-02-16 | 2007-02-16 | Proteínas quiméricas de toxoide de Shiga |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8846058B2 (enExample) |
| EP (1) | EP1991565B1 (enExample) |
| JP (1) | JP5409014B2 (enExample) |
| CA (1) | CA2642451C (enExample) |
| ES (1) | ES2532985T3 (enExample) |
| WO (1) | WO2007098201A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030170248A1 (en) * | 1997-12-23 | 2003-09-11 | Jeffrey R. Stinson | Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| EP1229045A1 (en) * | 2001-02-01 | 2002-08-07 | Institut Curie | Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| EP2420246A1 (en) * | 2006-04-20 | 2012-02-22 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Methods and compositions based on shiga toxin type 1 protein |
| US20090258010A1 (en) * | 2006-05-31 | 2009-10-15 | Thallion Pharmaceuticals, Inc. | Methods, compositions, and kits for treating shiga toxin associated conditions |
| AU2007254950A1 (en) * | 2006-05-31 | 2007-12-13 | Thallion Pharmaceuticals Incorporated | Methods, compositions, and kits for treating Shiga toxin associated conditions |
| EP2207793A2 (en) * | 2007-10-08 | 2010-07-21 | Rutgers, The State University | Nontoxic shiga-like toxin mutant compositions and methods |
| ES2614803T3 (es) * | 2009-01-23 | 2017-06-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Métodos y composiciones basadas en proteína tipo 2 de la toxina Shiga |
| CN101948546B (zh) * | 2010-09-25 | 2012-11-07 | 中国人民解放军军事医学科学院微生物流行病研究所 | 融合蛋白SAmB及其编码基因与应用 |
| EP3453770B1 (en) * | 2012-02-24 | 2021-04-21 | Gen-Probe Prodesse, Inc. | Detection of shiga toxin genes in bacteria |
| US9310368B1 (en) * | 2012-09-28 | 2016-04-12 | The United States Of America, As Represented By The Secretary Of Agriculture | High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2) |
| US9513287B1 (en) * | 2012-09-28 | 2016-12-06 | The United States Of America, As Represented By The Secretary Of Agriculture | High affinity monoclonal antibodies for detection of shiga toxin 2 |
| RU2573924C2 (ru) * | 2013-07-11 | 2016-01-27 | Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) | НЕТОКСИЧНЫЙ РЕКОМБИНАНТНЫЙ ШИГА ТОКСИН 2-ГО ТИПА (Stx2) |
| CN112851769A (zh) | 2014-01-27 | 2021-05-28 | 分子模板公司 | 用于哺乳动物中的去免疫化志贺毒素a亚基效应子多肽 |
| US11142584B2 (en) | 2014-03-11 | 2021-10-12 | Molecular Templates, Inc. | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same |
| CN113831416A (zh) | 2014-06-11 | 2021-12-24 | 分子模板公司 | 耐受蛋白酶切割的志贺毒素a亚基效应子多肽和包含其的细胞靶向分子 |
| KR20170110601A (ko) | 2015-02-05 | 2017-10-11 | 몰레큘러 템플레이츠, 인코퍼레이션. | 시가 독소 a 서브유닛 작동체 영역을 포함하는 다가 cd20 결합 분자 및 이들의 강화된 조성물 |
| MX2017015493A (es) | 2015-05-30 | 2018-02-09 | Molecular Templates Inc | Andamiajes de la subunidad a de la toxina shiga desinmunizados y moleculas con direccion a las celulas que los comprenden. |
| KR102557126B1 (ko) | 2016-12-07 | 2023-07-18 | 몰레큘러 템플레이츠, 인코퍼레이션. | 부위 특이적 접합을 위한 시가 독소 a 서브유닛 작동체 폴리펩타이드, 시가 독소 작동체 스캐폴드, 및 세포-표적화 분자 |
| EP3559239B1 (en) | 2016-12-22 | 2024-09-25 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung (IPK) | Oligomeric vaccines from plants by s-tag-s-protein fusions |
| ES2971981T3 (es) | 2017-01-25 | 2024-06-10 | Molecular Templates Inc | Moléculas de reconocimiento de células que comprenden efectores de la subunidad A de la toxina Shiga desinmunizados y epítopos de células T CD8+ |
| CN110612117B (zh) | 2018-04-17 | 2024-04-12 | 分子模板公司 | 包含去免疫化的志贺毒素a亚基支架的her2靶向分子 |
| CN111333734B (zh) * | 2020-03-31 | 2022-05-03 | 中国人民解放军军事科学院军事医学研究院 | 一种百日咳丝状血凝素融合蛋白及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552144A (en) * | 1992-01-22 | 1996-09-03 | Microcarb, Inc. | Immunogenic shiga-like toxin II variant mutants |
| WO1998011229A2 (en) | 1996-09-10 | 1998-03-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
-
2007
- 2007-02-16 EP EP07751283.8A patent/EP1991565B1/en not_active Not-in-force
- 2007-02-16 ES ES07751283.8T patent/ES2532985T3/es active Active
- 2007-02-16 WO PCT/US2007/004513 patent/WO2007098201A2/en not_active Ceased
- 2007-02-16 JP JP2008555421A patent/JP5409014B2/ja not_active Expired - Fee Related
- 2007-02-16 CA CA2642451A patent/CA2642451C/en not_active Expired - Fee Related
- 2007-02-16 US US12/279,423 patent/US8846058B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8846058B2 (en) | 2014-09-30 |
| CA2642451A1 (en) | 2007-08-30 |
| EP1991565A4 (en) | 2009-12-09 |
| CA2642451C (en) | 2016-12-20 |
| JP5409014B2 (ja) | 2014-02-05 |
| WO2007098201A2 (en) | 2007-08-30 |
| AU2007217782A1 (en) | 2007-08-30 |
| WO2007098201A3 (en) | 2009-04-16 |
| EP1991565A2 (en) | 2008-11-19 |
| EP1991565B1 (en) | 2015-01-21 |
| US20090226469A1 (en) | 2009-09-10 |
| JP2009527226A (ja) | 2009-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2532985T3 (es) | Proteínas quiméricas de toxoide de Shiga | |
| ES2563646T3 (es) | Composiciones y métodos relacionados con variantes de la proteína A (SpA) | |
| EA201170879A1 (ru) | Полипептиды с ксиланазной активностью | |
| AR069167A1 (es) | Variantes de alfa- amilasa de bacillus licheniformis con termoestabilidad aumentada y/o dependencia de calcio disminuida | |
| CL2018003148A1 (es) | Proteínas de fusión y usos de las mismas. | |
| AR069653A2 (es) | Variante de glucoamilasa original de aspergillus, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de la fermentacion y metodo para alterar la estabilidad termica. | |
| NZ598834A (en) | Prevention, treatment and diagnosis of P. gingivalis infection | |
| JO3182B1 (ar) | مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2 | |
| DK2333097T3 (da) | Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf | |
| ECSP093601A (es) | Proteínas derivadas del virus del síndrome de mancha blanca y sus usos | |
| AR074311A1 (es) | Variantes de subtilisina aislada de bacillus, con actividad proteolitica | |
| PE20120425A1 (es) | Metodos y composiciones en base a la proteina tipo 2 de la toxina shiga | |
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| WO2007064917A3 (en) | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | |
| SG178797A1 (en) | Oligosaccharide chain added glp-1 peptide | |
| CO2022010224A2 (es) | Variantes de alfa-glucosidasa ácida diseñadas por ingeniería | |
| AR064720A1 (es) | Microvesiculas derivadas de levadura recombinante con actividades hemostaticas y usos de las mismas | |
| UY37680A (es) | Proteína de fusión con polipéptido de extensión de vida media | |
| AR067980A1 (es) | Peptidos de cdh3 y agentes que los comprenden | |
| CO6290699A2 (es) | Termoestabilizacion de proteinas | |
| MX2020011083A (es) | Proteina. | |
| ECSP23035251A (es) | Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| BRPI0509168A (pt) | xilanases modificadas que exibem expressão melhorada | |
| AR071261A1 (es) | Variantes de proteasa para uso farmaceutico |